In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Foundations & Futures: Reimagining Public Health in the Artificial Intelligence Era
Strengthening Health Systems to Address Air Pollution in Ethiopia
Policy Brief: Childhood Blood Lead Surveillance in Indonesia – Findings and Policy Recommendations
Impact of Blue Lanes on Road Safety: Crashes, Speed and Motorcyclists’ Perceptions in…
Impacto da Faixa Azul na Segurança Viária: Sinistros, velocidade e percepções de motociclistas…
Culture is Medicine- a Model of Indigenous Harm Reduction in Practice
Trouble Brewing – The Case for Alcohol Policy (Second Edition)
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Clean Air in Jakarta: Gaps and Possibilities Toward Low Emission Practices